Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

A woman's cyclic Cushing syndrome was caused by a tumor in her adrenal gland that produced ACTH.

Treating classic 21-hydroxylase deficiency requires precise glucocorticoid dosing and attention to individual patient needs, with new treatments showing promise.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Hydrocortisone 17-butyrate 21-propionate ointment caused reversible side effects like skin issues, weight gain, and organ changes in dogs.

Prednisolone improved symptoms in a woman with Cronkhite-Canada syndrome, but regular screenings are needed due to cancer risk.

Triamcinolone is more effective and safer for treating feline pemphigus foliaceus than prednisone.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Prolonged use of topical corticosteroids can cause excessive hair growth.

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

Combination therapy may be more effective for difficult-to-treat scalp conditions.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

A woman with lupus developed rare skin growths that went away on their own.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Smaller, diluted corticosteroid injections reduce the risk of vision loss.

Depressed teens have different steroid levels in urine, which may help identify and treat them.

EPDS can cause recurring scalp sores and hair loss if not treated.

Topical DHEA safely increases skin oil production.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.